VIENNA, Austria–(HSMN NewsFeed)–Nabriva Therapeutics, a biotechnology company focused on developing a new class of antibiotics for serious infections caused by resistant pathogens, has announced the appointment of Dr David Chiswell as its Chief Executive…
Biopharmaceuticals, Personnel
Nabriva Therapeutics

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “Nabriva Therapeutics Appoints Dr David Chiswell as Chief Executive Officer”
Leave a Comment